Novartis Investigative Site

Trstená 549 16

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease, Chronic Obstructive Pulmonary Disease (COPD), Type 2 Diabetes Mellitus

Studies at this site

• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early
• A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) — Completed